Retail & Wholesale » Retail | McKesson Corp.

McKesson Corp. | Cash Flow

Fiscal year is April-March. All values USD Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,258
2,007
2,310
5,153
297
255
Depreciation, Depletion & Amortization
704
1,017
885
910
951
949
Other Funds
5
41
5
18
297
2,029
Funds from Operations
2,628
3,530
3,639
3,578
2,607
3,422
Changes in Working Capital
508
418
33
1,166
1,738
614
Net Operating Cash Flow
3,136
3,112
3,672
4,744
4,345
4,036
Capital Expenditures
415
545
677
562
580
Sale of Fixed Assets & Businesses
97
15
-
-
374
Purchase/Sale of Investments
-
-
939
506
1,469
Net Investing Cash Flow
5,046
677
1,557
3,796
1,522
Cash Dividends Paid - Total
214
227
244
253
262
Issuance/Reduction of Debt, Net
3,781
402
1,725
393
948
Net Financing Cash Flow
3,619
968
3,453
2,069
3,084
Net Change in Cash
1,737
1,148
1,293
1,265
111
Free Cash Flow
2,862
2,736
3,184
4,340
3,940
Deferred Taxes & Investment Tax Credit
16
171
64
882
868
189
Net Assets from Acquisitions
4,634
170
40
4,237
2,893
Other Sources
-
23
210
1,509
126
Change in Capital Stock
47
298
1,489
2,191
1,577
Exchange Rate Effect
28
319
45
144
150
Other Uses
94
-
111
-
18

About McKesson

View Profile
Address
6555 State Highway 161
Irving Texas 75039
United States
Employees -
Website http://www.mckesson.com
Updated 07/08/2019
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the McKesson Distribution Solutions and McKesson Technology Solutions business segments. The McKesson Distribution Solutions segment istributes brand, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs and other healthcare-related products worldwide.